Iridex Q2 FY26 net loss widens to $1.3 million; revenue falls 7% to $12.6 million
IRIX•Q2 revenue declines and net loss widens
IRIDEX posted Q2 2026 revenue of $12.6 million, down 7% from the prior-year quarter.
Net loss widened to $1.3 million, or $0.07 per share.
Product revenue trends and full-year outlook
Cyclo G6 product family revenue rose 19% to $3.9 million; probe volume climbed to 17,700, while system units fell to 18.
Retina product revenue dropped to $6.5 million, due to Middle East disruptions and reduced sell-through in China.
Full-year 2026 revenue outlook was reaffirmed at $51 million to $53 million; adjusted operating expenses are seen at $19 million to $19.5 million.
